MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 38 filers reported holding MILESTONE PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.71 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alta Fundamental Advisers LLC | 1,176,189 | $3,646,186 | 1.74% |
| Bleichroeder LP | 1,326,085 | $4,110,864 | 1.01% |
| BML Capital Management, LLC | 272,500 | $844,750 | 0.78% |
| VR Adviser, LLC | 2,208,812 | $6,847,317 | 0.72% |
| Lion Point Capital, LP | 450,207 | $1,395,642 | 0.62% |
| PVG ASSET MANAGEMENT CORP | 15,405 | $47,755 | 0.32% |
| Affinity Asset Advisors, LLC | 335,068 | $1,038,711 | 0.29% |
| RTW INVESTMENTS, LP | 3,256,102 | $10,093,916 | 0.21% |
| Ikarian Capital, LLC | 462,828 | $1,434,767 | 0.17% |
| Boxer Capital, LLC | 309,007 | $957,922 | 0.05% |
| Beta Wealth Group, Inc. | 14,127 | $43,794 | 0.03% |
| Clear Creek Financial Management, LLC | 31,429 | $97,430 | 0.02% |
| Valeo Financial Advisors, LLC | 120,699 | $374,167 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 48,796 | $151 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,695,291 | $5,255,402 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 27,588 | $85,523 | 0.00% |
| GOLDMAN SACHS GROUP INC | 2,558,724 | $7,932,044 | 0.00% |
| MARSHALL WACE, LLP | 113,187 | $350,880 | 0.00% |
| BARCLAYS PLC | 645,490 | $2,001 | 0.00% |
| LMR Partners LLP | 38,495 | $119,335 | 0.00% |
External links
This page lists MILESTONE PHARMACEUTICALS IN's shareholders in Q3 2023. To view MILESTONE PHARMACEUTICALS IN's shareholder history, click here.